Tuesday, March 21, 2017

Cerulean Pharma Inc. (CERU) Sank To A 3-Week Low After Dar‚ Bioscience Agreement

Cerulean Pharma Inc. (CERU) announced Monday morning that it has entered into a definitive stock purchase agreement with privately-held Dar‚ Bioscience through which equityholders of Dar‚ Bioscience will become the majority owners of Cerulean.

from RTT - Before the Bell http://ift.tt/2nhX6dt
via IFTTT

No comments:

Post a Comment